Hye Jung Bae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hye Jung Bae has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Hyun Jung Shin
Department of Pharmacy, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea
2 shared publicationsSeung Han Shin
Department of Pediatrics, Seoul National University Children’s Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea
2 shared publicationsYoon Sook Cho
Department of Pharmacy, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea
2 shared publicationsEe-Kyung Kim And Han-Suk Kim
Department of Pediatrics, Seoul National University Children’s Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea
1 shared publicationEe‐Kyung Kim
Department of Pediatrics Seoul National University Children's Hospital Jongno‐gu Seoul Republic of Korea
1 shared publicationEun Jung Cho
Department of Pharmacy, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 30 November 2021
- Published by The Korean Society of Health-System Pharmacists in Journal of Korean Society of Health-System Pharmacists
- Vol. 38 (4) , 450-461
Copper Deficiency and Evaluation in Infants Requiring Long-term Parenteral Nutrition
- 30 November 2021
- Published by The Korean Society of Health-System Pharmacists in Journal of Korean Society of Health-System Pharmacists
- Vol. 38 (4) , 450-461
Open AccessCopper Deficiency and Evaluation in Infants Requiring Long-term Parenteral Nutrition
- 19 October 2021
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 46 (5) , 1045-1053
Effect of selenium‐free parenteral nutrition on serum selenium of neonates and infants maintained on long‐term parenteral nutrition
Background: The risk of selenium deficiency increases for infants receiving long‐term parenteral nutrition (PN). This study analyzed selenium deficiency in neonates and infants requiring long‐term PN and evaluated the effect of intravenous (IV) selenium provision.Methods: This study was a retrospective study of neonates and infants who were admitted to a neonatal intensive care unit from January 2010 to December 2019, received PN for ≥2 weeks, and had their serum selenium concentration measured. Patients were divided into two groups, depending on their serum selenium concentration, a deficient group (n = 55) and a nondeficient group (n = 47).Results: Of the study participants, 53.9% (55 of 102) were deficient in selenium. No difference in demographic and clinical characteristics existed except bronchopulmonary dysplasia. A subgroup analysis was performed for patients (n = 29). The average dose of IV selenium administered to patients was 2.7 ± 1.0 mcg/kg/day. The average initial serum selenium concentration was 36.5 ± 18.0 mcg/L, and the serum concentration significantly increased to 52.5 ± 19.1 mcg/L after IV selenium administration (P < .001). The correlation between the average IV selenium dose and the change in serum selenium concentrations was statistically significant (r = .423; P = .022).Conclusion: Selenium deficiency is common in neonates and infants receiving long‐term PN. Serum selenium concentration increased proportionally as the IV selenium dose increased. Therefore, it is recommended to supply a proper dose of IV selenium depending on the degree of selenium deficiency.
- 19 October 2021
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 46 (5) , 1045-1053
Effect of selenium‐free parenteral nutrition on serum selenium of neonates and infants maintained on long‐term parenteral nutrition
Background: The risk of selenium deficiency increases for infants receiving long‐term parenteral nutrition (PN). This study analyzed selenium deficiency in neonates and infants requiring long‐term PN and evaluated the effect of intravenous (IV) selenium provision.Methods: This study was a retrospective study of neonates and infants who were admitted to a neonatal intensive care unit from January 2010 to December 2019, received PN for ≥2 weeks, and had their serum selenium concentration measured. Patients were divided into two groups, depending on their serum selenium concentration, a deficient group (n = 55) and a nondeficient group (n = 47).Results: Of the study participants, 53.9% (55 of 102) were deficient in selenium. No difference in demographic and clinical characteristics existed except bronchopulmonary dysplasia. A subgroup analysis was performed for patients (n = 29). The average dose of IV selenium administered to patients was 2.7 ± 1.0 mcg/kg/day. The average initial serum selenium concentration was 36.5 ± 18.0 mcg/L, and the serum concentration significantly increased to 52.5 ± 19.1 mcg/L after IV selenium administration (P < .001). The correlation between the average IV selenium dose and the change in serum selenium concentrations was statistically significant (r = .423; P = .022).Conclusion: Selenium deficiency is common in neonates and infants receiving long‐term PN. Serum selenium concentration increased proportionally as the IV selenium dose increased. Therefore, it is recommended to supply a proper dose of IV selenium depending on the degree of selenium deficiency.
- 15 June 2017
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 74 (12) , 904-918
Outcomes with perioperative fat emulsions containing omega-3 fatty acid: A meta-analysis of randomized controlled trials
Purpose Results of a meta-analysis of data from clinical studies comparing patient outcomes and hospital length of stay (LOS) in surgical patients receiving fish oil (FO)–containing i.v. fat emulsions (IVFEs) versus non–FO-containing IVFEs are presented. Methods Computerized searches of the MEDLINE, Embase, and Coch rane CENTRAL databases were performed in August 2014 to identify English-language articles on randomized controlled trials (RCTs) comparing FO-containing and non–FO-containing IVFEs in adult surgical patients receiving parenteral nutrition. Selected articles were analyzed for methodological and publication bias and study heterogeneity (I2 statistic). Results Data from 19 RCTs (total n = 1,167) were included in the meta-analysis. Compared with use of non–FO-containing IVFEs (products based in soybean oil [SO], medium-chain triglycerides, or olive oil), use of FO-containing IVFEs was associated with reduced infectious morbidity (odds ratio [OR], 0.44; 95% confidence interval [CI], 0.30–0.65; p < 0.0001; I2 = 0%); the effect size was greatest for FO-containing versus SO-based IVFEs. Relative to use of SO-based IVFEs, use of FO-containing IVFEs was associated with a significant reduction in hospital LOS (weighted mean difference, −2.70 days; 95% CI, −3.60 to −1.79 days; p < 0.00001; I2 = 0%). Conclusion The results of the meta-analysis indicated that FO-containing IVFEs could improve infectious morbidity and LOS. The overall effect of reducing infectious morbidity and LOS was found to be the greatest in comparison with the SO-based IVFEs.
- 15 June 2017
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 74 (12) , 904-918
Outcomes with perioperative fat emulsions containing omega-3 fatty acid: A meta-analysis of randomized controlled trials
Purpose Results of a meta-analysis of data from clinical studies comparing patient outcomes and hospital length of stay (LOS) in surgical patients receiving fish oil (FO)–containing i.v. fat emulsions (IVFEs) versus non–FO-containing IVFEs are presented. Methods Computerized searches of the MEDLINE, Embase, and Coch rane CENTRAL databases were performed in August 2014 to identify English-language articles on randomized controlled trials (RCTs) comparing FO-containing and non–FO-containing IVFEs in adult surgical patients receiving parenteral nutrition. Selected articles were analyzed for methodological and publication bias and study heterogeneity (I2 statistic). Results Data from 19 RCTs (total n = 1,167) were included in the meta-analysis. Compared with use of non–FO-containing IVFEs (products based in soybean oil [SO], medium-chain triglycerides, or olive oil), use of FO-containing IVFEs was associated with reduced infectious morbidity (odds ratio [OR], 0.44; 95% confidence interval [CI], 0.30–0.65; p < 0.0001; I2 = 0%); the effect size was greatest for FO-containing versus SO-based IVFEs. Relative to use of SO-based IVFEs, use of FO-containing IVFEs was associated with a significant reduction in hospital LOS (weighted mean difference, −2.70 days; 95% CI, −3.60 to −1.79 days; p < 0.00001; I2 = 0%). Conclusion The results of the meta-analysis indicated that FO-containing IVFEs could improve infectious morbidity and LOS. The overall effect of reducing infectious morbidity and LOS was found to be the greatest in comparison with the SO-based IVFEs.
- 22 May 2014
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 38 (5) , 914-920
Analysis of risk factors for lipid intolerance of intravenous fat emulsion in very low birth weight infants
In order to prevent fatty acid deficiency and to supply enough energy, intravenous fat emulsion is necessary for parenteral nutrition in preterm neonates. However, parenteral administration of intravenous fat emulsion can induce lipid intolerance. The purpose of this study was to analyze risk factors for lipid intolerance in very low birth weight infants. This retrospective study included 80 preterm neonates whose birth weight was less than 1,500 g. Subjects were divided into 2 categories: those with a serum triglyceride level of ≥ 200 mg/dl (n = 33, 41 %) and those with a serum triglyceride level of < 200 mg/dl (n = 47, 59 %). We conducted logistic regression analysis using variables which were significant in univariate analysis. All statistical analyses were processed in SPSS version 19.0. Four risk factors for lipid intolerance were obtained through analysis of the electronic medical record. Lipid intolerance occurred more frequently in neonates with sepsis; those with a birth weight less than 1,000 g; those who was administered intravenous fat emulsion more than 2.6 g/kg/day; and those whose gestational age was less than 28 weeks. It is suggested that serum triglyceride levels should be closely monitored to prevent lipid intolerance in preterm neonates with the aforementioned characteristics.
- 22 May 2014
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 38 (5) , 914-920
Analysis of risk factors for lipid intolerance of intravenous fat emulsion in very low birth weight infants
In order to prevent fatty acid deficiency and to supply enough energy, intravenous fat emulsion is necessary for parenteral nutrition in preterm neonates. However, parenteral administration of intravenous fat emulsion can induce lipid intolerance. The purpose of this study was to analyze risk factors for lipid intolerance in very low birth weight infants. This retrospective study included 80 preterm neonates whose birth weight was less than 1,500 g. Subjects were divided into 2 categories: those with a serum triglyceride level of ≥ 200 mg/dl (n = 33, 41 %) and those with a serum triglyceride level of < 200 mg/dl (n = 47, 59 %). We conducted logistic regression analysis using variables which were significant in univariate analysis. All statistical analyses were processed in SPSS version 19.0. Four risk factors for lipid intolerance were obtained through analysis of the electronic medical record. Lipid intolerance occurred more frequently in neonates with sepsis; those with a birth weight less than 1,000 g; those who was administered intravenous fat emulsion more than 2.6 g/kg/day; and those whose gestational age was less than 28 weeks. It is suggested that serum triglyceride levels should be closely monitored to prevent lipid intolerance in preterm neonates with the aforementioned characteristics.